- Oct 26, 2020

Fracture risk and management of discontinuation of denosumab therapy: a systematic review ...

Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, Langdahl B.

J Clin Endocrinol Metab. 2020 Oct 26:dgaa756. doi: 10.1210/clinem/dgaa756. Online ahead of print.

PMID: 33103722

See All

Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care ...

Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators...

To Break or Not to Break (Again): Is That the Question?

Kherani RB, Singh S. CRAJ. 2022;32(3):1 2 * Posted with permission from publisher

The role of osteoanabolic agents in the management of patients with osteoporosis

McClung MR, Rothman MS , Lewiecki EM, Hanley DA, Harris ST, Miller PD, Kendler DL. Postgrad Med. 2022 Aug;134(6):541-551. doi:...

Fracture risk and management of discontinuation of denosumab therapy: a systematic review ...

Related Posts

Comments